Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet

Last updated: May 5, 2017

CMS Measure ID: CMS164v5
Version: 5
NQF Number: 0068
Measure Description:

Percentage of patients 18 years of age and older who were diagnosed with acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) in the 12 months prior to the measurement period, or who had an active diagnosis of ischemic vascular disease (IVD) during the measurement period, and who had documentation of use of aspirin or another antiplatelet during the measurement period.

Initial Patient Population:

Patients 18 years of age and older with a visit during the measurement period who had an AMI, CABG, or PCI during the 12 months prior to the measurement year or who had a diagnosis of IVD overlapping the measurement year

Denominator Statement:

Equals Initial Population

Denominator Exclusions:

Patients who had documentation of use of anticoagulant medications overlapping the measurement year

Numerator Statement:

Patients who had an active medication of aspirin or another antiplatelet during the measurement year

Numerator Exclusions:

Not Applicable

Denominator Exceptions:

None

Measure Steward: National Committee for Quality Assurance
Domain: Effective Clinical Care
Next Version: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet
Previous Version: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
Improvement Notation:

Higher score indicates better quality

Guidance:

None

Addendum Notes: ICD-10 Value Set addition

Specifications

Release Notes

Header

  • Updated Clinical Recommendation Statement.

    Section: Clinical Recommendation Statement

    Source: Measure Lead

  • ​Updated Copyright.

    Section: Copyright

    Source: Annual Update

  • Added an exclusion for patients who used anticoagulant medications during the measurement year to align with the NQF-endorsed measure.

    Section: Denominator Exclusions

    Source: JIRA (CQM-1589)

  • Updated the measure description to more accurately reflect the measure intent.

    Section: Description

    Source: JIRA (CQM-1741)

  • Incremented eMeasure Version number.

    Section: eMeasure Version number

    Source: Annual Update

  • Removed guidance as it no longer applied.

    Section: Guidance

    Source: JIRA (CQM-1741)

  • Updated the Initial Population to more accurately reflect the measure intent.

    Section: Initial Population

    Source: JIRA (CQM-1741)

  • Updated Rationale.

    Section: Rationale

    Source: Measure Lead

  • Updated References.

    Section: Reference

    Source: Measure Lead

  • Updated measure title to harmonize with the endorsed measure title.

    Section: Title

    Source: JIRA (CQM-1741)

Logic

  • Added an exclusion for patients who used anticoagulant medications during the measurement year to align with the NQF-endorsed measure.

    Section: Denominator Exclusions

    Source: JIRA (CQM-1589)

  • Replaced datatypes 'Diagnosis, Active; Diagnosis, Inactive; Diagnosis, Resolved' with the re-specified 'Diagnosis' datatype to conform to QDM 4.2 changes.

    Section: Initial Population

    Source: QDM Standards

  • Updated the name of the value set from anti-thrombotics to antiplatelets to align with the content of the value set.

    Section: Numerator

    Source: JIRA (CQM-1589)

  • Replaced datatypes 'Diagnosis, Active; Diagnosis, Inactive; Diagnosis, Resolved' with the re-specified 'Diagnosis' datatype to conform to QDM 4.2 changes.

    Section: QDM Data Elements

    Source: QDM Standards

  • Value set Anticoagulant Medications (2.16.840.1.113883.3.464.1003.196.12.1283): Added Anticoagulant Medications.

    Section: QDM Data Elements

    Source: None

  • Value set Aspirin and Other Anti-thrombotics (2.16.840.1.113883.3.464.1003.196.12.1211): Renamed Aspirin and Other Anti-thrombotics to Aspirin and Other Antiplatelets.

    Section: QDM Data Elements

    Source: None

Value Set

  • Value set Acute Myocardial Infarction (2.16.840.1.113883.3.464.1003.104.12.1001): Added 21 ICD9CM codes. Added 15 ICD10CM codes.

    Section: None

    Source: None

  • Value set Anticoagulant Medications (2.16.840.1.113883.3.464.1003.196.12.1283): Added Anticoagulant Medications.

    Section: None

    Source: None

  • Value set Aspirin and Other Antiplatelets (2.16.840.1.113883.3.464.1003.196.12.1211): Deleted 7 RXNORM codes (243663, 246460, 252380, 403924, 432389, 435504, 435521).

    Section: None

    Source: None

  • Value set Aspirin and Other Anti-thrombotics (2.16.840.1.113883.3.464.1003.196.12.1211): Renamed Aspirin and Other Anti-thrombotics to Aspirin and Other Antiplatelets.

    Section: None

    Source: None

  • Value set Ischemic Vascular Disease (2.16.840.1.113883.3.464.1003.104.12.1003): Added 9 ICD9CM codes (414.3, 414.4, 437.0, 440.0, 440.30, 440.31, 440.32, 440.8, 440.9) and deleted 1 ICD9CM code(413.1). Added 206 ICD10CM codes and deleted 1 ICD10CM code (I20.1).

    Section: None

    Source: None

  • Value set Ischemic Vascular Disease (2.16.840.1.113883.3.464.1003.104.12.1003): Added 12 ICD10CM codes.

    Section: None

    Source: ICD-10 Addendum

External Resources